T he response of the heart to injury shares many of the features of wound healing that are observed in the lung, liver, kidney, and skin. Indeed, for each of these tissues, fibrosis represents a final common pathway that leads to organ dysfunction or failure. Myocardial fibrosis can result in excessive muscle-fiber entrapment, myocyte loss, myocyte atrophy, electric anisotropy, and reentrant arrhythmias or abnormal diastolic and systolic stiffness of the myocardium, each of which is sufficient to contribute to the development and progression of left ventricular dysfunction. 1 Although it is clear that progressive myocardial fibrosis is deleterious to the heart, and although previous studies have identified a number of molecules that are sufficient to provoke increased collagen synthesis in isolated cardiac fibroblasts in vitro and in experimental models in vivo (eg, platelet-derived growth factor, granulocyte colonystimulating factor, angiotensin II, aldosterone, endothelin, connective tissue growth factor [CCN2/CTGF], and transforming growth factor-␤ [TGF-␤]), 2, 3 it is not at all clear from existing studies exactly how or why wound healing becomes dysregulated in the adult mammalian heart. Indeed, whereas previous studies have suggested an important role for activation of the renin angiotensin system in the development of myocardial fibrosis (reviewed in Weber et al 1 ) , recent studies from this and other laboratories have suggested an important proximal role for proinflammatory cytokines in the initiation and progression of myocardial fibrosis. 4 -6 
Clinical Perspective on p 2116
Germane to the present discussion is the observation from several laboratories that transgenic mice with cardiacrestricted overexpression of the inflammatory mediator tumor necrosis factor (TNF) develop progressive myocardial fibrosis. 4 -6 Given that TNF inhibits collagen gene expression or collagen synthesis in cardiac fibroblasts, 7, 8 and therefore is not directly profibrotic, the mechanism(s) for the progressive fibrosis in the setting of sustained inflammatory signaling remains unknown. Here we show that increased mast cell density within the heart is required for the development of myocardial fibrosis and diastolic dysfunction in mice with sustained TNF signaling (MHCsTNF mice). Moreover, we show for the first time that cardiac fibroblasts exposed to sustained inflammatory signaling develop increased sensitivity to TGF-␤ and exhibit an increased repertoire of profibrotic phenotypic responses in response to mast cell mediators, suggesting that alterations in cardiac fibroblast phenotype may contribute to the development of dysregulated wound healing (fibrosis) during sustained inflammation in the heart.
Methods

Generation of Mouse Lines
MHCsTNF Transgenic Mice
The hemizygous line of transgenic mice with cardiac-restricted overexpression of cardiac-restricted TNF (referred to as MHCsTNF mice) has been described elsewhere in detail (C57BL/6 background). 6, 9 Briefly, these mice develop a heart failure phenotype that is characterized by progressive left ventricular (LV) dilation and progressive myocardial fibrosis from 8 to 12 weeks of age. Littermates (LM) lacking the TNF transgene were used as the appropriate controls.
Mast Cell-Deficient Mice
Genetically mast cell-deficient mice Kit W-sh /HNihrJaeBsmJ (referred to as c-kit Ϫ/Ϫ mice) 10 were purchased from Jackson Laboratory (Bar Harbor, ME) and out-crossed with MHCsTNF mice. The resulting F2 generation harboring the TNF transgene (c-kit ϩ/Ϫ ) were then back-crossed with homozygous c-kit Ϫ/Ϫ mice to generate the lines of mice used in these studies (F3 generation): LM/c-kit ϩ/Ϫ , MHCsTNF/c-kit ϩ/Ϫ , and MHCsTNF/c-kit Ϫ/Ϫ . All mice were housed under standard environmental conditions and were fed commercial chow and tap water ad libitum. All studies conformed to the principles of the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by Washington University School of Medicine in St. Louis and Baylor College of Medicine Animal Care and Use Committee.
Cell Culture
Cardiac Fibroblasts
Primary cultures of mouse cardiac fibroblasts were prepared from 12-week-old MHCsTNF and LM/c-kit Ϫ/Ϫ mice using a modification of previously published methods (see online-only Data Supplement). 11
Mast Cells
The murine MC/9 mast cell line was purchased from the American Type Culture Collection (Rockville, MD) and cultured in mast cell growth medium: DMEM (4.5 g/L glucose) with 6 mmol/L L-glutamine, 1.5 g/L sodium bicarbonate, 0.05 mmol/L 2-mercaptoethanol, 10% Rat T-STIM (Becton Dickenson, Catalog No. 354115), and 10% fetal bovine serum.
Cardiac fibroblasts were cocultured with mast cells under 2 different experimental conditions: (1) a transwell coculture system (Costar, Corning, NY) 12 and (2) 3-dimensional rat tail collagen I gels (Invitrogen GIBCO, Grand Island, NY). 13 For the transwell coculture studies, the fibroblasts were separated from the mast cells (final concentration 1ϫ10 6 cells/mL) by a porous polycarbonate membrane insert (0.4 m pore size). The mast cell/fibroblast cocultures were treated with diluent, recombinant human TGF-␤1 (2 ng/mL, R&D Systems, Minneapolis, MN), basic fibroblast growth factor (bFGF 25 ng/mL, Sigma-Aldrich, St. Louis, MO), NP-40208 (1 mol/L, a gift from Scios Inc, Freemont, CA), or losartan (100 mol/L, Sigma-Aldrich). The mast cell/fibroblast cocultures were incubated for 48 hours, and the fibroblasts were harvested and analyzed for ␣-smooth muscle actin (␣-SMA), BrdU incorporation, and collagen gene expression (see Characterization of Isolated Cardiac Fibroblasts section). Mast cell conditioned medium was also used to stimulate LM and MHCsTNF fibroblasts.
For the 3-dimensional (3-D) gel contraction assays, 13 cardiac fibroblasts from LM or MHCsTNF hearts were suspended in DMEM. Rat tail type I collagen was then added to a final gel concentration of 1.5 mg/mL. The number of fibroblasts in the final mixture was held constant at 1ϫ10 5 cells/mL. Mast cells were added to the collagen gels alone or along with the fibroblasts at a ratio (fibroblasts:mast cells) of 1:0, 1:1, or 1:10 (see the online-only Data Supplement). The cocultures were treated with diluent, NP-40208 (1 mol/L), losartan (100 mol/L), EGTA (5 mmol/L, Sigma-Aldrich), verapamil (50 mol/L, Sigma-Aldrich), and cromolyn (100 mol/L, Sigma-Aldrich). The surface area of the collagen gel was determined as a measure of the degree of gel contraction, and final results were expressed as a percentage of gel area at baseline.
Characterization of Isolated Cardiac Fibroblasts
To determine the mechanism(s) for the increased fibrosis in the MHCsTNF mouse hearts, we characterized fibroblast activation in cardiac fibroblasts isolated from 12-week-old MHCsTNF and LM mouse hearts. Fibroblast activation was measured as (1) the mean fluorescence intensity (MFI) of fibroblasts with ␣-SMA staining, (2) fibroblast proliferation (BrdU incorporation), and (3) fibroblast production of extracellular matrix components (collagen 1A1, 1A2, and 3A1 messenger RNA [mRNA] levels). 14 
␣-SMA Expression
Flow cytometry was used to determine the degree of ␣-SMA staining in cardiac fibroblasts isolated from LM and MHCsTNF mouse hearts (see the online-only Data Supplement). Cardiac fibroblasts were treated with diluent, recombinant human TNF (200U/mL, R&D Systems) or TGF-␤1 (2 ng/mL) for an additional 48 hours, and removed from the culture dishes. Flow cytometry (FACScalibur, Becton-Dickinson) was performed using a FITC conjugate antimouse ␣-SMA and an isotype-matched immunoglobulin G2a mouse (IgG2a) FITC conjugate as the appropriate control. The extent ␣-SMA staining in the fibroblast cultures was expressed as MFI.
Fibroblast Proliferation
Cardiac fibroblast proliferation was determined using the colorimetric Cell Proliferation ELISA, BrdU kit (Roche, Indianapolis, IN), as described. 15 The cell cultures were stimulated with TNF (200U/mL) and bFGF (25 ng/mL) for an additional 48 hours in serum-free media, followed by the addition of BrdU for 24 hours. All experiments were performed in triplicate.
(collagen 1A1 and 1A2) and collagen III (collagen 3A1) mRNA levels were quantified by real-time polymerase chain reaction in cardiac fibroblasts, as described (see the online-only Data Supplement). 16 
Cardiac Histology, Morphometry, and Function
Cardiac Mast Cells
Toluidine Blue staining was performed to identify the presence of mast cells in the LM, LM/c-kit ϩ/Ϫ , LM/c-kit Ϫ/Ϫ , MHCsTNF, MHCsTNF/c-kit ϩ/Ϫ , and MHCsTNF/c-kit Ϫ/Ϫ mouse hearts at 4, 8, and 12 weeks of age (see the online-only Data Supplement).
Myocardial Fibrosis
Myocardial collagen content was determined in the hearts from LM/c-kit ϩ/Ϫ , MHCsTNF/c-kit ϩ/Ϫ , and MHCsTNF/c-kit Ϫ/Ϫ mice at 4, 8, and 12 weeks of age using the picrosirius red technique, as described (see the online-only Data Supplement). 6
Cardiac Hypertrophy
Cardiac mass was assessed by determining the heart weight-to-body weight ratios of LM/c-kit ϩ/Ϫ , MHCsTNF/c-kit ϩ/Ϫ , and MHCsTNF/ c-kit Ϫ/Ϫ mice at 4, 8, and 12 weeks of age. 6
LV Diastolic Filling
Hearts from LM, LM/c-kit ϩ/Ϫ , c-kit Ϫ/Ϫ , MHCsTNF/c-kit ϩ/Ϫ , and MHCsTNF/c-kit Ϫ/Ϫ were isolated and perfused in the Langendorff mode, as described (see the online-only Data Supplement). 17
Myocardial Gene Expression
Total RNA was extracted from the hearts of LM/c-kit ϩ/Ϫ , MHC-sTNF/c-kit ϩ/Ϫ , and MHCsTNF/c-kit Ϫ/Ϫ mice using TRIzol reagent (Invitrogen, Carlsbad, CA) in order to assess TGF-␤ signaling and collagen gene expression (see the online-only Data Supplement).
Statistical Analysis
All results are expressed as meansϮSEM. Data were assessed with the use of commercially available statistical software (PASW statistics 17, SPSS Inc). Two-way ANOVA was used to evaluate mean differences in mast cell number, fibrillar collagen content; MFI of ␣-SMA, proliferation, gene expression, and percentage gel contraction; where appropriate, posthoc ANOVA testing was performed. Two-way repeated measures ANOVA was used to assess mean differences in percentage LV end-diastolic pressure. A P value Ͻ0.05 was considered statistically significant.
Results
Characterization of Cardiac Fibroblast Phenotype in MHCsTNF Hearts
To determine the mechanism(s) for the increased fibrosis in the MHCsTNF mouse hearts, we characterized fibroblast activation 14 in cardiac fibroblasts isolated from 12-week-old MHCsTNF and LM mouse hearts. As shown by the representative flow cytometric analysis illustrated in Figure 1A and the group data summarized in Figure 1B , the MFI for ␣-SMA staining was Ϸ1.2-fold (Pϭ0.012) greater in fibroblasts from MHCsTNF mouse hearts compared with fibroblasts from LM control. To determine whether TNF signaling was directly responsible for the increased myofibroblast differentiation, we treated MHCsTNF and LM fibroblasts MHCsTNF, transgenic mice with cardiac-restricted overexpression of tumor necrosis factor; a-SMA, ␣-smooth muscle actin; TNF, tumor necrosis factor; TGF-␤1, transforming growth factor ␤1; LM, littermate controls; bFGF, basic fibroblast growth factor; and mRNA, messenger RNA.
with exogenous TNF (200U/mL). Interestingly, exogenous TNF had no significant (Pϭ0.18) effect on myofibroblast differentiation whereas treatment with TGF-␤1 (2 ng/mL) resulted in a significant increase in ␣-SMA intensity in both MHCsTNF and LM fibroblasts compared with diluent-treated fibroblasts. Importantly, the degree of myofibroblast differentiation was significantly greater (Pϭ0.002) in the TGF-␤1treated MHCsTNF fibroblasts compared with the LM fibroblasts. Figure 1C shows that fibroblast proliferation was not significantly different in the LM and MHCsTNF fibroblasts. Moreover, treatment with TNF had no effect on fibroblast proliferation in LM and MHCsTNF fibroblasts. In contrast, treatment with bFGF, which was used as a positive control, resulted in a significant (Pϭ0.001) increase in LM and MHCsTNF fibroblast proliferation compared with diluenttreated cells; however, there was no significant difference in BrdU incorporation between the bFGF-treated LM and MH-CsTNF fibroblasts. Figure 1D through 1F shows that there was no increase in collagen gene expression in the LM and MHCsTNF fibroblasts at baseline, nor after stimulation with TNF. In contrast, TGF-␤1 stimulation significantly increased collagen 1A1 and 1A2 mRNA levels in LM and MHCsTNF fibroblasts but had no effect on collagen 3A1 mRNA levels. Importantly, there was no significant difference in collagen 1A1 and 1A2 gene expression between the TGF-␤1-treated LM and MHCsTNF fibroblasts. Viewed together, these observations suggest that sustained TNF signaling had a small effect on fibroblast activation and raise the interesting possibility that the myocardial fibrosis observed in the MHCsTNF mice was mediated indirectly.
Role of Mast Cells in TNF-Induced Myocardial Fibrosis
Previous studies have shown that inflammation at the site of tissue injury leads to increased mast cell homing to the site of injury. 18 -20 To explore the possibility that mast cells accumulated in the hearts of the MHCsTNF transgenic mice, we determined mast cell number in the LM and MHCsTNF mouse hearts at 4, 8, and 12 weeks of age. Figure 2B shows that there was a significant increase in mast cell number in the MHCsTNF mouse hearts at 4 (1.8 fold, Pϭ0.04), 8 (3.9 fold, PϽ0.001), and 12 (2.4 fold, PϽ0.001) weeks compared with LM controls. As shown in Figure 2B , although mast cells were present in low numbers in the hearts of LM mice, there was no significant change in mast cell number in these hearts from 4 to 12 weeks of age. Noting previous studies which showed that mast cells accumulate in areas of ongoing tissue fibrosis, [21] [22] [23] we next asked whether the increase in mast cell number observed in the MHCsTNF mouse hearts contributed to the myocardial fibrosis. To address this question, we out-crossed MHCsTNF mice with c-kit Ϫ/Ϫ mice. Crossing the MHCsTNF mice into a c-kit Ϫ/Ϫ background significantly attenuated the increase in mast cells observed in the MHC-sTNF mice at 4, 8, and 12 weeks of age (online-only Data Supplement Figure I ). Figure 3A shows representative picrosirius red staining for myocardial collagen content in the LM/c-kit ϩ/Ϫ , MHCsTNF/c-kit ϩ/Ϫ , and MHCsTNF/c-kit Ϫ/Ϫ hearts whereas Figure 3B depicts the results of group data. As we reported previously, there was a progressive increase in myocardial collagen content from 4 to 12 weeks of age in the MHCsTNF mice compared with LM controls. 6 However, the salient finding shown by Figure 3B is the myocardial collagen content was significantly (Pϭ0.031) attenuated by 8 weeks of age in the MHCsTNF/c-kit Ϫ/Ϫ hearts compared with MHCsTNF/c-kit ϩ/Ϫ hearts and was completely abrogated by 12 weeks of age (Pϭ0.12) compared with LM/ckit ϩ/Ϫ . The difference in collagen content in the MHCsTNF/ c-kit Ϫ/Ϫ mouse hearts was not secondary to a primary defect in c-kit Ϫ/Ϫ cardiac fibroblasts insofar as the degree of ␣-SMA activation and BrdU incorporation was not significantly different in the c-kit Ϫ/Ϫ and LM fibroblasts at baseline or in response to TGF-␤1 and bFGF stimulation. Moreover, the c-kit Ϫ/Ϫ fibroblasts were more sensitive to TGF-␤1-stimulated collagen gene expression compared with LM controls (online-only Data Supplement Figure II) .
To determine the effect of mast cells on LV diastolic filling, we measured LV pressure-volume relationships in the LM/c-kit ϩ/Ϫ , MHCsTNF/c-kit ϩ/Ϫ , and MHCsTNF/c-kit Ϫ/Ϫ mouse hearts by Langendorff buffer perfusion at 12 weeks of age. As shown in Figure 3C , there was a significant (Pϭ0.002) leftward shift in the LV pressure-volume curve in the MHCsTNF/c-kit ϩ/Ϫ hearts compared with LM/c-kit ϩ/Ϫ mouse hearts, consistent with our prior observations in this model. 24 Importantly, the LV pressure-volume curve was normalized in MHCsTNF/c-kit Ϫ/Ϫ mice (Pϭ0.58) compared with LM/c-kit ϩ/Ϫ , consistent with the normalization of collagen content in these mice. The rightward shift in the pressure-volume curves from the MHCsTNF/c-kit Ϫ/Ϫ mouse hearts was not secondary to intrinsic differences in the LV pressure-volume relationship in c-kit Ϫ/Ϫ mouse hearts, which were not different from LM control hearts (see online-only Data Supplement Figure III ). The Table shows that the heart-weight to body-weight ratio was significantly greater (Pϭ0.002, Pϭ0.014, Pϭ0.002) in the MHCsTNF/c-kit ϩ/Ϫ mice than in the LM/c-kit ϩ/Ϫ mice at 4, 8, and 12 weeks of age. In contrast, the heart-weight to body-weight ratio in the MHCsTNF/c-kit Ϫ/Ϫ mice was not significantly different (Pϭ0.06) from LM/c-kit ϩ/Ϫ mice at 12 weeks of age.
We have shown that TGF-␤ signaling through the T␤R I contributes to the increase in fibrillar collagen content in MHCsTNF mice. 6, 24 Given that mast cells secrete preformed TGF-␤ as well as components of the renin-angiotensin system, which are capable of upregulating TGF-␤ signaling, 25 we examined TGF-␤1, TGF-␤2, T␤R I, and T␤R II mRNA expression in LM/c-kit ϩ/Ϫ , MHCsTNF/ c-kit ϩ/Ϫ and MHCsTNF/c-kit Ϫ/Ϫ mouse hearts. Figure 4 shows that TGF-␤1 and TGF-␤2 mRNA levels were increased significantly (Pϭ0.04 and Pϭ0.002 for TGF-␤1; Pϭ0.02 and PϽ0.001 for TGF-␤2) at 8 and 12 weeks, and that T␤R I and T␤R II mRNA levels were increased (PϽ0.001 for T␤R I, Pϭ0.041 for T␤R II) at 12 weeks of age in the MHCsTNF/c-kit ϩ/Ϫ hearts compared with LM/ c-kit ϩ/Ϫ . Importantly, both TGF-␤1 and T␤RI mRNA were attenuated significantly (Pϭ0.03, Pϭ0.01) at 12 weeks of age in the MHCsTNF/c-kit Ϫ/Ϫ hearts compared with the MHCsTNF/c-kit ϩ/Ϫ mice, suggesting a previously unanticipated role for mast cells in modulating TGF-␤ expression in this inflammatory cardiomyopathy model. 6 Similarly, immunohistochemistry showed that TGF-␤ protein levels were decreased in the MHCsTNF/c-kit Ϫ/Ϫ mice compared with MHCsTNF/c-kit ϩ/Ϫ mice (see online-only Data Supplement Figure IV) .
Mast Cell-Fibroblast Interactions
The above studies suggested an important role for mast cells in the development and progression of myocardial fibrosis in the MHCsTNF mice. Accordingly, we next asked whether there were interactions between mast cells and cardiac fibroblasts, as well as whether there were qualitative or quantitative differences in the degree of interaction in cardiac fibroblasts exposed to sustained TNF signaling. Figure 5A shows 2 important findings. First, coculture of mast cells with cardiac fibroblasts resulted in a significant (PϽ0.001) increase in ␣-SMA staining in LM and MHCsTNF fibroblasts compared with diluents-treated fibroblasts; however, the degree was significantly greater (PϽ0.001) in MHCsTNF fibroblasts. Moreover, these effects were mimicked by conditioned media from mast cells-treated MHCsTNF fibroblasts. Second, treatment with the T␤R I antagonist NP-40208 significantly (Pϭ0.02) attenuated the mast cell induced increase of ␣-SMA staining in fibroblasts isolated from MHCsTNF hearts, suggesting that the mast cell induced increase in myofibroblast activation was secondary to TGF-␤ signaling. Given that angiotensin II induces the expression of TGF-␤1 26 and given that mast cells are capable of local regulation of the renin angiotensin system in the heart, 27 we treated the mast cell/cardiac fibroblasts cocultures with losartan, an angiotensin type 1 receptor antagonist. Figure 5A shows that there was no significant (Pϭ0.13) difference in mast cell-induced ␣-SMA staining in MHCsTNF fibroblasts treated with losartan whereas there was a significant decrease in ␣-SMA staining in MHCsTNF fibroblasts treated with losartanϩNP-40208. Figure 5B shows that coculturing mast cells with cardiac fibroblasts resulted in a significant (PϽ0.001) increase in BrdU incorporation in LM and MHCsTNF fibroblasts compared with diluent-treated fibroblasts; however, the degree of BrdU incorporation was significantly greater (PϽ0.001) in MHCsTNF fibroblasts. Similar findings were obtained using mast cell-conditioned media. Treatment with NP-40208 significantly (Pϭ0.039) attenuated the mast cell-induced increase in BrdU incorporation in MHCsTNF fibroblasts and completely abrogated the mast cell-induced increase in BrdU incorporation in LM fibroblasts. In contrast, there was no significant difference (Pϭ0.11) in BrdU incorporation in the losartanϩNP-40208 - treated mast cell-cocultured fibroblasts from LM mouse hearts whereas there was a significant (Pϭ0.048) difference in BrdU incorporation in the mast cell-cocultured fibroblasts from MHCsTNF mouse hearts treated with losartanϩNP-40208 compared with NP-40208 treated cells. Insofar as our in vivo studies suggested that myocardial mast cells contributed to the increased levels of TGF-␤ and T␤R mRNA (Figure 4 ) in the MHCsTNF mice, we asked whether coculturing mast cells with cardiac fibroblasts was sufficient to increase TGF-␤ and T␤R mRNA in vitro. As shown in the online-only Data Supplement ( Figure V) , there was no significant difference in the mRNA expression levels for TGF-␤1, TGF-␤2, T␤R I and T␤R II mRNA in diluenttreated LM and MHCsTNF fibroblasts. However, coculturing mast cells with fibroblasts resulted in a significant increase in expression of TGF-␤1 and T␤R I mRNA in both LM and MHCsTNF fibroblasts; moreover, TGF-␤1 and T␤R I mRNA levels were significantly (Pϭ0.02, Pϭ0. 045) greater in the MHCsTNF fibroblasts than in the LM fibroblasts. In contrast, coculturing mast cells with cardiac fibroblasts had no effect on TGF-␤2 and T␤R II mRNA levels in either MHCsTNF or LM fibroblasts. Taken together, these results suggest that paracrine signaling between cardiac fibroblasts and mast cells provokes fibroblast activation in both LM and MHCsTNF fibroblasts, at least in part through a TGF-␤-mediated signaling pathway, but that MHCsTNF fibroblasts are qualitatively and quantitatively more sensitive to the paracrine effects of mast cells.
To determine whether mast cells directly influenced collagen gene expression in isolated cardiac fibroblasts, we examined collagen gene expression in the mast cell/cardiac fibroblast coculture system. In control experiments we established that Angiotensin II (1 mol/L) was sufficient to increase collagen 1A1, 1A2, and 3A1 mRNA expression in LM and MHCsTNF fibroblasts and that the concentration of losartan used was sufficient to block collagen gene expression (data not shown). Figure 6 shows that coculturing fibroblasts with mast cells or mast cell-conditioned media resulted in significant increases in collagen 1A1, 1A2, and 3A1 (Pϭ0.02, Pϭ0.03, and Pϭ0.02) mRNA in LM fibroblasts (compared with diluent) and increases in collagen 1A1 (PϽ0.001), 1A2 (Pϭ0.004), and collagen 3A1 (Pϭ0.001) mRNA levels in MHCsTNF fibroblasts. Moreover, the mast cell-induced increase in collagen 1A1, 1A2, and 3A1 mRNA expression was significantly greater (Pϭ0.02, Pϭ0.03, Pϭ0.02) for MHCsTNF fibroblasts compared with LM fibroblasts. Treatment with NP-40208 abrogated the mast cell-induced increased collagen gene expression in both LM and MHCsTNF fibroblasts (Pϭ0.56 -0.82 compared with diluent). Treatment with losartan also abrogated the mast cell-induced increase in collagen 1A1 gene expression in both LM (Pϭ0.09) and MHCsTNF (Pϭ0.07) cocultured fibroblasts compared with diluent; however, the mast cellinduced increase in collagen 1A2 and 3A1 gene expression was not sensitive to losartan in both LM and MHCsTNF fibroblasts. Treatment with losartanϩNP-40208 resulted in a significant decrease in collagen 1A1 gene expression compared with NP-40208 alone in LM (Pϭ0.04) and MHCsTNF (Pϭ0.04) fibroblasts.
Effect of Mast Cells on 3-D Collagen Gel Contraction
To determine whether cross talk between mast cells and cardiac fibroblasts had an effect on collagen remodeling, we coseeded mast cells and fibroblasts in a 3-D rat tail collagen I gel. 13, 28 Figure 7A depicts representative collagen gels seeded with mast cells alone, LM and MHCsTNF fibroblasts alone, and collagen gels seeded with a 1:1 or 1:10 ratio of fibroblasts to mast cells. The fibroblast cell number was constant across all experiments. As shown by the group data depicted in Figure 7B , mast cells alone had no effect on contraction of the 3-D collagen gels. However, coculturing mast cells with cardiac fibroblasts resulted in a mast celldependent contraction of the 3-D gel (PϽ0.001), with increasing gel contraction in relation to increasing concentration of mast cells in the gel.
However, the important finding shown by Figure 7B is that mast cell-induced gel contraction was significantly (PϽ0.001) greater for fibroblasts from the MHCsTNF transgenic mice than for fibroblasts from LM hearts. Interestingly, when LM and MHCsTNF fibroblasts were cultured in the 3-D collagen gels alone they demonstrated slender filopodia. However, when fibroblasts were cocultured in the gel together with mast cells their filopodia became more prominent, consistent with the appearance of myofibroblasts, which may provide a mechanistic explanation for the increased gel . Two-way ANOVA revealed a significant difference in MHCsTNF fibroblast activation (PϽ0.001) and proliferation (PϽ0.001) compared with LM fibroblasts; ␣-SMA staining and BrdU incorporation were significantly greater in MHCsTNF diluent-treated and mast cell-cocultured fibroblasts compared with the respective LM fibroblasts, and these differences were sensitive to inhibition with NP-40208, but not to losartan. The increase in BrdU incorporation in mast cell-cocultured LM fibroblasts was also sensitive to inhibition with NP-40208, but not to losartan. ␣-SMA staining and BrdU incorporation were significantly decreased in MHCsTNF fibroblasts treated with NP-40208ϩlosartan compared with NP-40208 treated alone. Similar findings were obtained using mast cell-conditioned media. All experiments were performed in triplicate. (*PϽ0.05 compared with the respective diluent-treated LM and MHCsTNF fibroblasts; †PϽ0.05 compared with the LM mast cell cocultured fibroblasts). ␣-SMA indicates ␣ smooth muscle actin; MFI, mean fluorescence intensity; LM, littermate control; MHCsTNF, transgenic mice with cardiac-restricted overexpression of tumor necrosis factor; and NS, not significant. contraction observed in the coculture system ( Figure 7C ). As shown in Figure 7D , NP-40208 had a small but significant (Pϭ0.01) effect in terms of attenuating the degree of the gel contraction in the MHCsTNF fibroblasts when cultured alone or when seeded with mast cells. In contrast, losartan had no effect on the collagen gel contraction in the MHCsTNF fibroblasts when cultured alone or when seeded with mast cells. Interestingly, mast cell-induced collagen gel contraction was significantly attenuated by EGTA (Pϭ0.002), and was almost completely abolished by verapamil (PϽ0.001), suggesting that the observed increase in mast cell-induced gel contraction was calcium dependent. Similar overall results were obtained in LM fibroblasts (online-only Data Supplement Figure VI) . The mast cell stabilizer cromolyn sodium had no effect on mast cell-induced gel contraction (the Table and the online-only Data Supplement), suggesting that the observed effects of mast cells on gel contraction were not histamine dependent.
Discussion
The results of this study, in which we examined the mechanisms of myocardial fibrosis in a transgenic mouse model of sustained TNF signaling, suggest that increased mast cell density with resultant mast cell-cardiac fibroblast cross-talk is required for the development of myocardial fibrosis. Here we also show for the first time that cardiac fibroblasts exposed to sustained inflammatory signaling exhibit an increased repertoire of profibrotic phenotypic responses in response to mast cell mediators. The following lines of evidence support these statements. First, we observed that the number of cardiac mast cells increased significantly in the hearts of MHCsTNF mice at 8 to 12 weeks of age ( Figure  2A ), which coincides with the development of myocardial fibrosis in this mouse model. 6 Second, breeding the MHC-sTNF mice onto a mast cell-deficient background signifi- Heart weight-to-body weight ratios were determined in LM/c-kit ϩ/Ϫ , MHC-sTNF/c-kit ϩ/Ϫ , and MHCsTNF/c-kit Ϫ/Ϫ mice at 4, 8, and 12 weeks of age (*PϽ0.05 compared with LM/c-kit ϩ/Ϫ mouse hearts at the respective time periods by 2-way ANOVA). LM/c-kit ϩ/Ϫ indicates littermate controls that are heterozygous for the Kit W-sh mutation; MHCsTNF/c-kit ϩ/Ϫ , transgenic mice with cardiacrestricted overexpression of tumor necrosis factor that are heterozygous for the Kit W-sh mutation; and MHCsTNF/c-kit Ϫ/Ϫ , transgenic mice with cardiac-restricted overexpression of tumor necrosis factor that are homozygous for the Kit W-sh mutation.
cantly attenuated the myocardial fibrillar collagen content and the progressive time-dependent upregulation of TGF-␤1, ␤2, and T␤R I and II mRNA expression in MHCsTNF mice (Figures 3 and 4 ). 6 The changes in myocardial collagen content were functionally significant insofar as the leftward shift of the LV pressure-volume curve was abolished in MHCsTNF mice that were bred onto a mast cell-deficient background ( Figure 3B ). Moreover, these results are internally consistent with our previous observation that the progressive myocardial fibrosis and leftward shift of the LV pressure-volume curve in this model was sensitive to inhibition with a T␤R I antagonist. 24 Third, the coculture experiments suggest that mast cells provoked increased fibroblast activation in MHCsTNF fibroblasts, as well as increased type I (collagen 1A1) and type III (collagen 3A1) gene expression and fibroblast proliferation in LM and MHCsTNF fibroblasts ( Figures 5 and 6 ). The mast cell-induced changes in LM and MHCsTNF fibroblasts were sensitive to inhibition with the T␤R I antagonist NP-40208. Nonetheless, we cannot exclude a potentially important role for other profibrotic mast cell mediators (eg, tryptase, chymase). Although not definitive, our results suggest that 1 mechanism for the sensitivity to TGF-␤ signaling in the LM and MHCsTNF fibroblasts may relate to increased T␤R I expression (online-only Data Supplement Figure IV) in the fibroblasts that were cocultured with mast cells. In contrast, the mast cell-induced changes in the fibroblasts were only partially sensitive to inhibition of the angiotensin type 1 receptor with losartan ( Figure 5 ), suggesting that the profibrotic effects of mast cells are predominately mediated through the effects of TGF-␤ on cardiac fibroblasts.
The mast cell-induced changes in LM and MHCsTNF fibroblasts in vitro were functionally significant insofar as the degree of 3-D collagen gel contraction was directly correlated with an increased ratio of mast cells to fibroblasts in the gel ( Figure 7B ). Moreover, the degree of gel contraction in the cocultures was greater for the MHCsTNF fibroblasts than for LM fibroblasts, consistent with the increase in ␣-SMA expression in the MHCsTNF fibroblasts. Further evidence that collagen gel contraction was mediated by ␣-SMA in the fibroblasts is supported by the observation that collagen gel contraction was completely abrogated by treating the cultures with EGTA or verapamil ( Figure 7D and online-only Data Supplement Figure VI) , which would have decreased the amount of calcium available for ␣-actin-induced fibroblast contraction. Consistent with the findings discussed above on the effects of mast cell-released TGF-␤, the mast cellinduced increase in 3-D collagen gel contraction was sensitive to inhibition with NP-40208 whereas losartan had no effect. One limitation of these studies is that we did not address the mechanism for the increased mast cell density in the MHCsTNF mice. Mast cells arise from hematopoietic progenitor cells but do not circulate in the blood; instead they acquire their mature phenotype locally in the tissues where they reside. 29 Insofar as intravenous transfer of bone marrow-derived cultured mast cells does not result in engraftment of mast cells into the heart, 30 it was not possible to perform mast cell knock-in experiments in the MHCsTNF/c-kit Ϫ/Ϫ mice to determine whether increased mast cell homing or increased mast cell proliferation within the heart was responsible for the increased mast cell density in the MHCsTNF mice.
Role of Mast Cells in the Failing Heart
Although mast cells have been implicated in chronic inflammatory conditions that lead to fibrosis in the liver, lungs, and skin (reviewed in Metz et al 29 ) , the role of mast cells in the failing heart, wherein sustained inflammation and myocardial fibrosis contribute to adverse cardiac remodeling, is comparatively less well understood. Although previous studies have demonstrated a direct relationship between mast cell density and collagen volume fraction in experimental [31] [32] [33] and human heart failure, 34 -36 a direct cause-and-effect relationship between the mast cells and the development of myocardial fibrosis has not been previously established. Previous studies that have employed chymase inhibitors 37 or mast cell stabilizing agents 31, 38 have demonstrated decreased myocardial fibrosis in experimental models and thus provide indirect supportive evidence for a potential role for mast cell-induced myocardial fibrosis in heart failure. However, it should be recognized that chymase inhibitors decrease the local production of angiotensin II, a profibrotic peptide, in the heart. Moreover, mast cell stabilizing agents (eg, cromolyn, nedocromil, and ketotifen) inhibit the release of neutrophil-derived proinflammatory mediators and have a variety of other effects on nitric oxide production and phospholipase C activation and NADPH expression. 39 Thus, mast cell stabilizing agents have mechanisms that are independent of their effects on stabilizing mast cell membranes. Here we show that mast cell density increases in the hearts of MHCsTNF mice in direct relationship to the development of myocardial fibrosis in a mast cell-sufficient background and that breeding the MHC-sTNF onto a mast cell-deficient background decreases mast cell density, abrogates myocardial fibrosis, and improves diastolic filling, thereby establishing a direct causal relationship between mast cell density and progressive myocardial fibrosis. Our results are qualitatively similar but quantitatively different from those of Hara and colleagues, who reported a significant decrease in perivascular fibrosis, with only a trend toward a decrease in interstitial fibrosis in mast cell-deficient (WBB6F1-W/W v ) mice after pressure overload. 40 With regard to the cellular mechanisms for mast cell-induced fibrosis, previous studies have shown that mast cells release a variety of preformed profibrotic mediators such as TGF-␤ and bFGF, which directly stimulate fibroblast activation and proliferation. Our mast cell coculture experiments are consistent with these prior reports and show that mast cell secretory products provoke a profibrotic phenotype in both LM and MHCsTNF fibroblasts (Figures 5 and 6 ) and that fibroblasts isolated from a transgenic model of sustained inflammatory signaling exhibit an enhanced repertoire of profibrotic phenotypic responses to mast cell mediators compared with LM fibroblasts.
Conclusions
The present study shows for the first time that sustained inflammatory signaling in the heart leads to progressive myocardial fibrosis and diastolic cardiac dysfunction through a mechanism that requires increased myocardial mast cell density, with a resultant increase in TGF-␤mediated profibrotic signaling between cardiac mast cells and resident cardiac fibroblasts. Apart from the novelty of these findings, this study further suggests that sustained TNF signaling results in increased sensitization of resident fibroblasts to the biological mediators released by mast cells, including enhanced responsiveness to TGF-␤. From a teleological standpoint these inflammation-induced changes in the cardiac fibroblasts may be beneficial by allowing resident cardiac fibroblasts to be more efficient in terms of myocardial repair mechanisms at sites of injury and inflammation; however, in the long term these changes may be maladaptive and contribute to excessive myocardial fibrosis and pathological remodeling. Whether the observed pathological fibrosis observed in inflammatory cardiomyopathy represents increased fibroblast sensitivity to TGF-␤ signaling or whether it represents a profibrotic response secondary to increased mast cell density or both is not known, and whether these results will obtain in the human myocardium will require further study.
